Galipienzo J, Otta-Oshiro R J, Salvatierra D, Medrano C, López-Rojo I, Linero M
Servicio de Anestesia, MD Anderson Cancer Center, Madrid, España.
Servicio de Urología, MD Anderson Cancer Center, Madrid, España.
Rev Esp Anestesiol Reanim. 2022 Jan;69(1):25-33. doi: 10.1016/j.redar.2021.03.006. Epub 2021 Apr 23.
Surgical treatment during COVID-19 pandemic is controversial. Currently, most clinical guidelines advise to defer surgical patients during the COVID-19 pandemic, although the supporting data is sparse. We assumed that a COVID-19-free hospital, on the back of strong isolation measures and targeted screening, could reduce complications and enable us to continue treating high-risk patients.
Prospective study with retrospective analysis of 355 patients who had undergone nondeferrable oncological surgery between March 16th, 2020, and April 14th, 2020, at our institution. The aim of the study was to assess the hospital restructuring and surgical protocols to be able to safely handle non-deferrable surgeries during the first wave of the COVID-19 pandemic. We implemented structural changes and an updated surgical-anesthetic protocol in order to isolate COVID-19 patients from other surgical patients. Comprehensive targeted screening for COVID-19 patients was made. PCR tests were requested for suspected COVID-19 patients. We analyzed mortality and complications related to both surgery and COVID-19 during hospital admission and also 15 and 30 days after surgery. We compared it with a sample of similar patients in the pre-pandemic period.
Of the 355 patients enrolled in our study, 21 were removed due to COVID-19 infection, leaving a total of 334 patients in our final analysis. Post-operative complications were found in 37 patients (11.07%). Two patients died after surgery (0.6%). At the end of the study, COVID-19-related adverse outcomes were detected in six patients (1.79%). When comparing the complications of our original sample with the complications that occurred in the pre-COVID era, we found no statistically significant differences.
Our results show that the surgical treatment of oncologic patients during the COVID-19 pandemic is safe, as long as the hospital performs surgeries under strict isolation measures and a robust screening method. It is necessary to select COVID-19 free hospitals for this matter in this and future pandemics.
在新冠疫情期间进行手术治疗存在争议。目前,大多数临床指南建议在新冠疫情期间推迟手术患者的治疗,尽管支持这一建议的数据并不充分。我们认为,一家通过严格隔离措施和针对性筛查实现无新冠病毒感染的医院,可以减少并发症,并使我们能够继续治疗高危患者。
对2020年3月16日至2020年4月14日在我们机构接受不可推迟的肿瘤手术的355例患者进行前瞻性研究并进行回顾性分析。本研究的目的是评估医院的结构调整和手术方案,以便在新冠疫情第一波期间能够安全地处理不可推迟的手术。我们实施了结构调整和更新的手术麻醉方案,以便将新冠患者与其他手术患者隔离开来。对新冠患者进行了全面的针对性筛查。对疑似新冠患者进行了聚合酶链反应检测。我们分析了住院期间以及术后15天和30天与手术和新冠相关的死亡率和并发症。我们将其与疫情前时期的一组类似患者样本进行了比较。
在我们研究纳入的355例患者中,21例因新冠感染被排除,最终分析中共计334例患者。37例患者(11.07%)出现术后并发症。两名患者术后死亡(0.6%)。在研究结束时,6例患者(1.79%)出现与新冠相关的不良后果。当将我们原始样本的并发症与新冠疫情前时期发生的并发症进行比较时,我们发现没有统计学上的显著差异。
我们的结果表明,在新冠疫情期间,只要医院在严格的隔离措施和完善的筛查方法下进行手术,肿瘤患者的手术治疗就是安全的。在本次及未来的疫情中,选择无新冠病毒感染的医院来处理此事是必要的。